Lead development of state-of-the-art generative and predictive ML models for antibody sequence and structure, mentor ML staff, set research strategy, and deploy lab-in-the-loop protein design methods to produce real therapeutic antibodies validated in a high-throughput wet lab.
The role: We are seeking a creative, accomplished Assoc. Director or Principal Machine Learning Scientist to advance the state of the art in ML-driven therapeutic antibody design.
At BigHat Biosciences our full-stack antibody drug development platform uses ML to drive every stage from discovery to optimization. Our roboticized high-throughput wet-lab continually adds to our large proprietary datasets, which are piped through a custom LIMS++ data management and orchestration layer to automatically update and deploy the latest models. This makes the development of complex, next-gen therapeutics ‘trivially parallelizable’, at a pace which only accelerates as we develop better ML tooling.
You’re not interested in just git-cloning the latest NeurIPS pub and swapping out the dataset. Motivated by an enthusiasm for the possibility of addressing unmet patient needs and a curiosity about the underlying biology, you’ll apply your world-class ML skillset to refine and expand this state-of-the-art protein engineering platform. Success will mean not only hands-on methods development, but helping shape the direction for future ML research, and actively participating in the application of our platform to the accelerated design of new therapeutics.
Key Responsibilities
- Design and implement the next state-of-the-art generative models of antibody sequence and structure, and predictive models of antibody properties, trained on proprietary internal datasets of thousands to millions of antibodies.
- Provide leadership, technical guidance, and mentorship to other ML and data science FTEs and interns.
- Help set strategy for future ML research, driven by a strong high-level understanding of BigHat programs and operations as well as real-world drug development challenges.
- Develop, refine, and deploy de novo design methods for generating initial hits to challenging, therapeutically interesting targets.
- Develop multi-modality, multi-objective iterative protein sequence optimization approaches to lab-in-the-loop antibody design problems for validation and deployment in our high-throughput wet lab - at BigHat success is only declared upon synthesis of real antibodies with drug-like properties.
- Maintain an in-depth understanding of the current state-of-the-art in ML-driven protein engineering, both in the literature and at BigHat.
- Share your findings at top-tier conferences and publish in leading scientific journals to advance the field of protein engineering.
- Provide ML expertise and support for ongoing therapeutics programs, directly contributing to the development of new drugs.
- Collaborate with our engineering team to ensure maximal efficiency in the automated and agentic deployment of our latest models to our therapeutics programs.
- Work closely with an interdisciplinary team of drug developers, wet lab scientists, automation specialists, data scientists, etc. to identify inefficiencies or potential improvements in BigHat’s platform, and plan and prioritize ML methods development accordingly.
Skills Knowledge and Expertise
- PhD in ML/CS or in the hard sciences with 5+ years experience post-graduation in developing and applying novel ML methods, and a strong quantitative background.
- Publications in major ML conferences and/or leading journals, and an extensive demonstrable track record developing and applying novel ML in industry.
- Strong competency in Python, familiarity with PyTorch, and experience with modern software engineering best practices.
- Excellent communication skills, sufficient biomedical domain knowledge to interact effectively with diverse scientific teams.
- Enjoys a fast-paced environment and excels at executing across multiple projects.
- Familiarity with the current state-of-the-art in ML-driven protein engineering
- Nice-to-haves include experience with de novo design, NGS data, Bayesian optimization, familiarity with antibody biology and drug development, and experience training and deploying models on AWS.
Total Rewards
The salary estimated for this position is $254,000 - $290,000 + bonus + options + benefits. Compensation will vary depending on job-related knowledge, skills, and experience. Actual compensation will be confirmed in writing at the time of the offer.
What BigHat Offers:
What BigHat Offers:
- Range of health insurance plan options through Anthem and Kaiser (monthly credit if benefit waived)
- Dental, and vision coverage through Guardian
- Additional well-being benefits through Nayya, OneMedical, Wagmo, Rula, and more
- 401(k) with company match
- DTO, two weeks of company-wide shutdown, and 12 company holidays
- Paid parental leave
About
BigHat Biosciences designs safer, more effective biologic therapies for patients using machine learning and synthetic biology. BigHat integrates a wet lab for high-speed characterization with machine learning technologies to guide the search for better antibodies. We apply these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.BigHat is a Series B biotech outside San Francisco with a team-oriented, inclusive, and family-friendly culture. Our broad pipeline of wholly-owned and partnered therapeutic programs span many disparate indications with high unmet need, such as cancer, inflammation, and infectious disease. BigHat has raised >$100M from top investors, including Section 32, a16z, and 8VC.
BigHat Biosciences San Mateo, California, USA Office
1900 Alameda de Las Pulgas, San Mateo, CA, United States, 94403
Similar Jobs
AdTech • Big Data • Digital Media • Software
Design, develop, and support large-scale big data platforms and ETL pipelines using Java, Spark, Hadoop, Kafka and related tooling. Build end-to-end data services, troubleshoot production issues, perform data quality and performance tuning, and collaborate across teams to deliver data for reporting and analytics.
Top Skills:
Data WarehouseDruidETLGitHadoopJavaJenkinsJIRAKafkaLinuxMapr HadoopPerlPythonScalaShellSparkSQLUnix Shell
Artificial Intelligence • Hardware • Information Technology • Machine Learning
The Manager of Technical Enablement will oversee validation and qualification efforts for DRAM products, ensure team alignment, and manage communication between engineering and customers to drive product success.
Top Skills:
CloudComputer EngineeringDramElectrical EngineeringHigh-Performance ComputingKnowledge RepositoriesSemiconductor EngineeringTracking SystemsValidation Documentation
Aerospace • Information Technology • Software • Cybersecurity • Design • Defense • Manufacturing
Support 737NG/MAX propulsion service engineering by investigating and resolving in-service propulsion issues, communicating with airlines and suppliers, developing mitigation plans, updating maintenance documentation, leading fleet-wide projects, and providing on-site technical assistance as needed.
Top Skills:
Aircraft Maintenance ManualBoeing Communication SystemBoeing Drawing SystemsFault Isolation ManualMy Boeing Fleet
What you need to know about the San Francisco Tech Scene
San Francisco and the surrounding Bay Area attracts more startup funding than any other region in the world. Home to Stanford University and UC Berkeley, leading VC firms and several of the world’s most valuable companies, the Bay Area is the place to go for anyone looking to make it big in the tech industry. That said, San Francisco has a lot to offer beyond technology thanks to a thriving art and music scene, excellent food and a short drive to several of the country’s most beautiful recreational areas.
Key Facts About San Francisco Tech
- Number of Tech Workers: 365,500; 13.9% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Google, Apple, Salesforce, Meta
- Key Industries: Artificial intelligence, cloud computing, fintech, consumer technology, software
- Funding Landscape: $50.5 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Sequoia Capital, Andreessen Horowitz, Bessemer Venture Partners, Greylock Partners, Khosla Ventures, Kleiner Perkins
- Research Centers and Universities: Stanford University; University of California, Berkeley; University of San Francisco; Santa Clara University; Ames Research Center; Center for AI Safety; California Institute for Regenerative Medicine


.jpeg)
